Legal entity
All 1 tracked stories fall under one category: court-decisions. AstraZeneca is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Each story carries 2 original sources on average, compared with 2.8 for the broader beat in this window.
Last mentioned: Aug 1, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 1 tracked stories fall under one category: court-decisions. AstraZeneca is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Each story carries 2 original sources on average, compared with 2.8 for the broader beat in this window. Their average consequence score of 6 runs above the beat's 5.8 for that window. Tenth Circuit Court of Appeals appears in 1 tracked Legal story from August 1, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 28 Legal stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Tenth Circuit Court of Appeals. Shared-story counts are live from our verified record — not editorial picks.
Tenth Circuit reverses and remands
A three-judge panel holds that the PREP Act immunizes all claims for loss, including breach of contract, but remands for the lower court to determine whether AstraZeneca waived immunity via the informed consent form.
District court denies motion to dismiss
A federal district judge rules that Dressen's breach-of-contract claim may not be barred by the PREP Act's immunity, allowing the lawsuit to proceed.
Clinical trial participation and alleged injury
Brianne Dressen receives AstraZeneca's COVID-19 trial vaccine and later experiences debilitating symptoms. She signs an informed consent form stating the company would cover injury-related medical costs.
In a significant interpretation of the PREP Act, a Tenth Circuit panel held that the statute's immunity extends to contractual damages, rejecting a plaintiff's breach-of-contract theory. The court also remanded to consider whether AstraZeneca's informed consent form constituted a waiver of that immunity.
Tenth Circuit Court of Appeals is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
